Tumor‐induced immune dysfunction: the macrophage connection KD Elgert, DG Alleva, DW Mullins Journal of leukocyte biology 64 (3), 275-290, 1998 | 580 | 1998 |
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional … DW Mullins, SL Sheasley, RM Ream, TNJ Bullock, YX Fu, VH Engelhard The Journal of experimental medicine 198 (7), 1023-1034, 2003 | 282 | 2003 |
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy TA Colella, TNJ Bullock, LB Russell, DW Mullins, WW Overwijk, ... The Journal of experimental medicine 191 (7), 1221-1232, 2000 | 203 | 2000 |
CXC chemokine receptor 3 expression by activated CD8+ T cells is associated with survival in melanoma patients with stage III disease IM Mullins, CL Slingluff, JK Lee, CF Garbee, J Shu, SG Anderson, ... Cancer research 64 (21), 7697-7701, 2004 | 166 | 2004 |
Antigens derived from melanocyte differentiation proteins: Self‐tolerance, autoimmunity, and use for cancer immunotherapy VH Engelhard, TNJ Bullock, TA Colella, SL Sheasley, DW Mullins Immunological reviews 188 (1), 136-146, 2002 | 164 | 2002 |
Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment FS Varn, Y Wang, DW Mullins, S Fiering, C Cheng Cancer research 77 (6), 1271-1282, 2017 | 158 | 2017 |
Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells TNJ Bullock, DW Mullins, VH Engelhard The Journal of Immunology 170 (4), 1822-1829, 2003 | 143 | 2003 |
Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide DW Mullins, CJ Burger, KD Elgert The Journal of Immunology 162 (11), 6811-6818, 1999 | 141 | 1999 |
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge JR Baird, KT Byrne, PH Lizotte, S Toraya-Brown, UK Scarlett, ... The Journal of Immunology 190 (1), 469-478, 2013 | 124 | 2013 |
Extracellular hepatitis C virus core protein activates STAT3 in human monocytes/macrophages/dendritic cells via an IL-6 autocrine pathway RS Tacke, A Tosello-Trampont, V Nguyen, DW Mullins, YS Hahn Journal of Biological Chemistry 286 (12), 10847-10855, 2011 | 110 | 2011 |
Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma GV Yamshchikov, DW Mullins, CC Chang, T Ogino, L Thompson, ... The Journal of Immunology 174 (11), 6863-6871, 2005 | 99 | 2005 |
Multiple murine BRafV600E melanoma cell lines with sensitivity to PLX4032 MH Jenkins, SM Steinberg, MP Alexander, JL Fisher, MS Ernstoff, MJ Turk, ... Pigment cell & melanoma research 27 (3), 495, 2014 | 97 | 2014 |
Manipulation of avidity to improve effectiveness of adoptively transferred CD8+ T cells for melanoma immunotherapy in human MHC class I-transgenic mice TNJ Bullock, DW Mullins, TA Colella, VH Engelhard The Journal of Immunology 167 (10), 5824-5831, 2001 | 97 | 2001 |
Immunity to melanoma antigens: from self‐tolerance to immunotherapy CL Slingluff Jr, KA Chianese‐Bullock, TNJ Bullock, WW Grosh, ... Advances in immunology 90, 243-295, 2006 | 74 | 2006 |
Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma LT Dengel, AG Norrod, BL Gregory, E Clancy-Thompson, MD Burdick, ... Journal of immunotherapy 33 (9), 965-974, 2010 | 73 | 2010 |
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel β2-microglobulin loss-of-function in melanoma cells CC Chang, T Ogino, DW Mullins, JL Oliver, GV Yamshchikov, N Bandoh, ... Journal of Biological Chemistry 281 (27), 18763-18773, 2006 | 70 | 2006 |
Adaptive immunity programmes in breast cancer FS Varn, DW Mullins, H Arias‐Pulido, S Fiering, C Cheng Immunology 150 (1), 25-34, 2017 | 68 | 2017 |
BRAF inhibition alleviates immune suppression in murine autochthonous melanoma SM Steinberg, P Zhang, BT Malik, A Boni, TB Shabaneh, KT Byrne, ... Cancer immunology research 2 (11), 1044-1050, 2014 | 68 | 2014 |
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses JA Lo, M Kawakubo, VR Juneja, MY Su, TH Erlich, MW LaFleur, ... Science translational medicine 13 (581), eabd8636, 2021 | 65 | 2021 |
Immune responses to the HLA-A* 0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A* 0201-transgenic mice DW Mullins, TNJ Bullock, TA Colella, VV Robila, VH Engelhard The Journal of Immunology 167 (9), 4853-4860, 2001 | 63 | 2001 |